| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9287 | 
      | Human Intestinal Absorption | HIA+ | 0.9452 | 
      | Caco-2 Permeability | Caco2- | 0.5484 | 
      | P-glycoprotein Substrate | Substrate | 0.7861 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.7046 | 
                                                     | Inhibitor | 0.8388 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8299 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6141 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8333 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9116 | 
      | CYP450 3A4 Substrate | Substrate | 0.6868 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9291 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9230 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.7960 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8682 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7272 | 
                                                                    | Non-inhibitor | 0.7484 | 
      | AMES Toxicity | Non AMES toxic | 0.8475 | 
      | Carcinogens | Non-carcinogens | 0.9519 | 
      | Fish Toxicity | High FHMT | 0.9919 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9997 | 
      | Honey Bee Toxicity | High HBT | 0.8405 | 
      | Biodegradation | Not ready biodegradable | 0.8819 | 
      | Acute Oral Toxicity | III | 0.6226 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7315 |